RA Capital Management CBLL Position
Exited5-Fund ConvergenceRA Capital Management exited their position in Ceribell, Inc. (CBLL) in Q2 2025, after holding the stock for 3 quarters.
The position was first reported in Q4 2024 and has been tracked across 3 quarterly 13F filings.
CBLL is a convergence signal: 5 specialist biotech funds hold this stock, suggesting high institutional conviction.
About Ceribell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
Full company profile →Short Interest
6.6%
5.0 days to cover
RA Capital Management CBLL Position History
Frequently Asked Questions
Does RA Capital Management own CBLL?
No. RA Capital Management exited their position in Ceribell, Inc. (CBLL) in Q2 2025. They previously held the stock for 3 quarters.
How many hedge funds own CBLL?
5 specialist biotech hedge funds currently hold CBLL, including Redmile Group, Driehaus Capital, Perceptive Advisors and 2 more. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did RA Capital Management first buy CBLL?
RA Capital Management's position in CBLL was first reported in Q4 2024. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is RA Capital Management's CBLL position increasing or decreasing?
RA Capital Management completely exited their CBLL position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
CBLLCompany Page →
All fund holders, insider trades, catalysts, and cash runway
RA Capital ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →